- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: patients with multiple myeloma
Total 200563 results
-
Bristol-Myers SquibbAbbVieCompleted
-
CelgeneCompleted
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Bristol-Myers SquibbWithdrawnMultiple MyelomaKorea, Republic of
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
University Hospital, ToulouseMinistry of Health, France; Janssen, LPCompletedMultiple MyelomaFrance, Belgium
-
University of Heidelberg Medical CenterGerman Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials HeidelbergActive, not recruitingRelapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K MutationGermany
-
Margarida Magalhaes-SilvermanNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Primary Systemic Amyloidosis | Light Chain Deposition Disease | Extramedullary Plasmacytoma | Isolated Plasmacytoma of BoneUnited States
-
University of WashingtonNational Cancer Institute (NCI); SecuraBioTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
Promontory Therapeutics Inc.CompletedMultiple MyelomaUnited States
-
SanofiCompletedPlasma Cell MyelomaUnited States, Czechia, France
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs HospitalCompleted
-
Corvus Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Cartesian TherapeuticsCompletedMultiple MyelomaUnited States
-
Cartesian TherapeuticsCompleted
-
Centre Hospitalier le MansCompleted
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaCanada
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Italy, Spain, Germany
-
Rigshospitalet, DenmarkCompletedNeoplasms | Lymphoma | Hematologic Diseases | Leukemia, Myeloid | Multiple Myeloma | Bone Marrow TransplantationDenmark
-
SCRI Development Innovations, LLCNovartis; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
ItalfarmacoTerminatedMultiple MyelomaItaly
-
AbbVieSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia (AML)United States, Germany, United Kingdom
-
Genenta ScienceIRCCS San RaffaeleTerminated
-
Tel-Aviv Sourasky Medical CenterCompletedPlasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Myeloma, Plasma-CellIsrael
-
CelgeneCompletedMultiple MyelomaNetherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
-
MorphoSys AGCompletedLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, United Kingdom, Austria, Germany, Italy, Poland
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Oncopeptides ABWithdrawnMultiple Myeloma | Relapse Multiple MyelomaCzechia
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Glaxo WellcomeCompletedHIV Infections | AIDS Dementia ComplexUnited States
-
Emory UniversityMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
Weijun FuNanjing Legend Biotech Co.Active, not recruiting
-
Zurich University of Applied SciencesKing's College London; Celgene Corporation; Kantonsspital Aarau; Klinik Hirslanden... and other collaboratorsTerminated
-
CelgeneCompletedNeoplasm Metastasis | Prostate Cancer | Chronic Lymphocytic Leukemia | Glioblastoma Multiforme | Squamous Cell Carcinoma of Head and Neck | Ewing's OsteosarcomaUnited States, Spain, France, Germany
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)WithdrawnLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder and other conditions
-
CelgeneTerminatedMultiple MyelomaSpain
-
University of Heidelberg Medical CenterCompleted
-
National Cancer Institute (NCI)CompletedHematologic NeoplasmsUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder | Secondary...United States
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedNeurotoxicity | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Gilead SciencesTerminatedMultiple MyelomaUnited States
-
CelgeneCompleted